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904 The Journal of Thoracic and CardioBackground: Cell transplantation improves heart function after myocardial infarc-
tion. This study investigated the survival of implanted cells in normal and infarcted
myocardium.
Methods: Male rat aortic smooth muscle cells were cultured. For the in vitro study,
male smooth muscle cells mixed with female smooth muscle cells or male smooth
muscle cells injected into a piece of female rat myocardium were used to evaluate
the accuracy of quantitative real-time polymerase chain reaction to measure Y
chromosomes. For the in vivo study, 2 million live or dead male smooth muscle
cells were injected into normal or infarcted female myocardium. At 1 hour and 1 and
4 weeks after transplantation, hearts, lungs, and kidneys were harvested for mea-
surement of Y chromosomes.
Results: In vitro, the accuracy of polymerase chain reaction measurement was
excellent in cultured cells (r2  0.996) and the myocardium (r2  0.786). In vivo,
1 hour after 2  106 cell implantation, live cell numbers decreased to 1.0  0.2 
106 and 1.1  0.3  106, and dead cell numbers decreased to 0.9  0.2  106 and
0.8  0.2  106 in the normal and infarcted myocardium, respectively (P  .01 for
all groups). Lungs and kidneys contained 8.5% and 1.5% of the implanted cells, but
no cells were detected at 1 week. At 1 week, no dead smooth muscle cells were
detected in the normal or infarcted myocardium. The numbers of live cells at 1 and
4 weeks were 0.48 0.06 106 and 0.27 0.07 106 in normal myocardium and
0.29  0.08  106 and 0.18  0.05  106 in infarcted myocardium.
Conclusions: One hour after implantation, only 50% of smooth muscle cells re-
mained in the implanted area. Some implanted cells deposited in other tissue.
Implanted cell survival progressively decreased durin
vascular Surgery ● April 2005g the 4-week study.
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TXCell transplantation has come of age.1 Re-cent experimental and clinical reports havesuggested that transplanted cells preventventricular dilation and dysfunction.2-4 Thebenefits of cell implantation on heart func-tion were proportional to the number of
cells injected.5 Although a variety of interventions have
been proposed to increase cell survival to enhance the
functional benefit,6,7 techniques to evaluate cell survival in
the implanted heart have not been well established.
A variety of methods have been used to evaluate cell
survival after myocardial transplantation, including micro-
scopic observation, assays for -galactosidase activity, and
terminal deoxynucleotidyl transferase-mediated dUTP nick
end labeling (TUNEL) staining assay.7 Unfortunately, these
methods are semiquantitative, and data could not provide
precise quantitation of the survival of the implanted cells.
Recently, Müller-Ehmsen and associates8 used real-time
polymerase chain reaction (PCR) targeting the Y chromo-
some to measure the number of neonatal rat cardiomyocytes
that survived transplantation into the female rat myocar-
dium.
In this study we evaluated the accuracy and reproduc-
ibility of quantitative real-time PCR to measure the Y
chromosome. Then we studied the survival of transplanted
male rat smooth muscle cells (SMCs) into normal or in-
farcted female rat myocardium by using the real-time PCR
assay. Lungs, kidneys, and brain were also harvested at
different times after cell transplantation to determine
whether the implanted cells leaked from the implanted site
of the heart.
Materials and Methods
Experimental Animals
Adult male Lewis rats (weighing 250-300 g) were used as cell
donors, and female Lewis rats (weighing 200-250 g) were recipi-
ents. All procedures were approved by the Animal Care Commit-
tee of the Toronto General Research Institute and were performed
in compliance with the Guide to the Care and Use of Experimental
Animals of the Canadian Council on Animal Care and the Guide
for the Care and Use of Laboratory Animals published by the US
National Institutes of Health (publication no. 85-23; revised 1996).
Preparation of Donor Cells
SMCs were selected for this study because they might be an ideal
choice for implantation to stabilize an infarct region and prevent
ventricular dilation and dysfunction after a myocardial infarc-
tion.9,10 Implantation of these cells provided a functional improve-
ment similar to that with fetal cardiomyocytes11 or skeletal muscle
myoblasts.12 We elected to study SMCs transplantation because
these cells can be easily harvested from peripheral vessels, they
readily proliferate in vitro, they can be cryopreserved, and they
respond to hemodynamic stresses with hypertrophy and hyperpla-
The Journal of Thoracisia. The aorta of male Lewis rats was excised and washed with
phosphate-buffered saline (PBS), and the surrounding connective
tissue was removed. The endothelial cells were removed with
trypsin, and the aorta was minced and incubated in 10 mL of PBS
containing 0.2% trypsin (Difco; Invitrogen Corp, Invitrogen
Canada Inc, Burlington, Canada), 0.1% type II collagenase
(Worthington; Biochemical Corp, Lakewood NJ), and 0.02% glu-
cose for 10 minutes at 37°C. The supernatant containing the
isolated cells was transferred into 20 mL of culture medium
(Iscove modified Dulbecco medium; Invitrogen Corp) containing
10% fetal bovine serum (Invitrogen Corp), 0.1 mol/L -mercap-
toethanol, 100 U/mL penicillin, and 100 g/mL streptomycin. This
procedure was repeated 3 times. The cell suspension was then
centrifuged at 600g for 5 minutes at room temperature. The cell
pellet was resuspended in cultured medium and cultured. The cells
were subcultured, and the second-passage cells were used for the
studies. Cultured SMCs were identified immunohistochemically
by using a monoclonal antibody against -smooth muscle actin
(Sigma-Aldrich, St Louis, Mo) as previously described.9,10
Preparation of Cells Immediately Before Implantation
Live cells. The cultured SMCs were detached by the addition
of 0.05% trypsin in PBS to the culture dish for 3 minutes. Then 10
mL of Iscove modified Dulbecco medium without serum was
added to the dish, and the cell suspension was centrifuged 580g for
3 minutes. The cell pellet was resuspended at a concentration of 2
 106/50 L for cell transplantation.
Dead cells. To examine the time required for the adult rat heart
to break down the DNA of irreversibly injured male SMCs after
transplantation, cultured SMCs were killed by exposing them to
80°C for 5 minutes before cell transplantation. The death of the
cells was confirmed by culturing studies.
Labeled cells. To identify the transplanted SMCs in the recip-
ient myocardium, cells were cultured to 50% confluence and then
labeled with 5-bromo-2=-deoxyuridine (BrdU; Zymed Lab Inc,
South San Francisco, Calif) by adding 25 L of a 0.4% solution to
10 mL of cultured medium for 24 hours before transplantation, as
previously described.9,10
In Vitro Evaluation of Accuracy and Reproducibility
The accuracy and reproducibility of real-time PCR for measuring
cell numbers were evaluated by the following methods:
1. The reproducibility of real-time PCR was evaluated with a
standard curve.13 Genomic DNA of 107 SMCs was ex-
tracted, and the DNA was dissolved in 200 L of water. A
4-L sample corresponding to 105 copies of male Y-
chromosomal DNA was diluted to produce samples, which
had a range from 101 to 105 copies. Male SMCs isolated
from 4 individual rats were used for evaluation of repro-
ducibility. The number of cycles at which fluorescence
exceeded the threshold was analyzed by real-time PCR, as
described in the next section.
2. The accuracy of the assay and the interference of female
cell DNA on the measurement of the male cell counts were
evaluated by assaying mixtures of male and female cells.14
A total of 105 cell populations were prepared so that the
proportion of male to female cells varied: 0.1%, 1%, 10%,
c and Cardiovascular Surgery ● Volume 129, Number 4 905
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TXor 100% (n  5 in each group). The number of male cells
was then measured with a real-time PCR technique.
3. To evaluate the effect of heart tissue and DNA extraction
from tissue on accuracy and reproducibility, male cells
(0.5, 1.0, 2.0, or 4.0  106) were injected into 300 mg of
female heart tissue in a test tube (n  5 for each group).
The myocardium was immediately frozen in liquid nitro-
gen. The tissues were ground into a fine powder in a
precooled mortar and pestle for DNA extraction. the num-
Figure 1. A, Amplification plots after serial dilutions o
(SMCs). In brief, the genomic DNA of 1  107 SMCs wa
(2 L) were diluted from 1:10 to 1:104. The samples we
correspond to the copy number of male cells. B, Dis
extracted from male cells. C, Dissociation curves of th
female myocardium 4 weeks after male SMC transplan
those in panel B.ber of male cells was evaluated with real-time PCR.
906 The Journal of Thoracic and Cardiovascular Surgery ● ApriQuantitative Analysis of Y-Chromosomal DNA by
Real-Time PCR
The DNA of the cells or tissue was extracted with the Qiagen Kit
(Qiagen, Mississauga, Ontario, Canada). The DNA was dissolved
in 200 L of water, and the total amount of DNA was measured
by spectrophotometry.
Real-time PCR was performed with SYBR-Green (Applied
Biosystems, Foster City, Calif). The SYBR-Green I dye binds to
the double-stranded product, resulting in an increase in fluores-
ndard DNA extracted from male smooth muscle cells
racted and dissolved in 200 L of water. DNA samples
plified by real-time PCR. The numbers from 101 to 105
tion curves of the PCR products from genomic DNA
R product from DNA samples extracted from infarcted
n. The dissociation curves in panel C were similar tof sta
s ext
re am
socia
e PC
tatiocence detected by the ABI 7900HT Sequence Detection System
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TX(Applied Biosystems). Figure 1, A illustrates the amplification plot
of the target gene in this experimental setting. A specific sequence
of rat Sry3 gene in the Y chromosome was targeted. The genomic
DNA taken from male SMCs was used to obtain a standard curve
as described previously. The primer pairs (30 nmol/L) were GCA
TTT ATG GTG TGG TCC CGC GG and GGC ACT TTA ACC
CTT CGA TGA GGC.15 The cycling conditions were 5 minutes
at 50°C, 10 minutes at 95°C for activation of polymerase, and
then 30 seconds at 95°C for denaturation, 60 seconds at 62°C
inducing annealing, and 30 seconds at 72°C for extension.
Forty-five cycles were used. After amplification, dissociation
curves were obtained to discriminate between specific and
nonspecific products (Figure 1, B and C ).
Coronary Artery Ligation
An anterior myocardial infarction was created by ligation of the
proximal left anterior descending artery of adult female rats for
cell transplantation, as previously described.16,17
Cell Transplantation
Live and dead cells were implanted into normal and infarcted
myocardium at 3 weeks after left anterior descending artery liga-
tion. Under general anesthesia, the heart was exposed through a
median sternotomy. A purse-string suture was placed around the
proposed injection site in the anterior wall of the left ventricle to
avoid leakage of cells after injection. Live or dead SMCs (2 
106/50 L) were injected with an insulin syringe into a single site
of the anterior wall near the apex through the purse-string suture.
After transplantation, the purse-string suture was tied and left to
mark the implantation site. The chest was then closed, and the
animals were allowed to recover.
At 1 hour, 1 day, 1 week, and 1 month after cell transplantation,
the hearts were harvested. The left ventricular free wall, including
the implantation site, was dissected. The samples were frozen in
liquid nitrogen and stored at 80°C until DNA extraction, as
described previously.
Lungs, brains, and kidneys were harvested 1 hour and 1 week
after transplantation. Those tissues were divided to extract DNA in
the same manner as with heart. Quantitative analysis of male cells
was performed with real-time PCR.
Histology
The heart sections were fixed in 5% glacial acetic acid in methanol,
embedded in paraffin, and cut into 10-m-thick slices. The slices
were stained with hematoxylin and eosin as described in the
manufacturer specifications (Sigma). Implanted cells at the trans-
planted region were identified by immunohistochemical staining
for BrdU as previously described.9,10
Statistical Analysis
The results were expressed as mean  SE. Comparisons between
groups were evaluated by a 2-way analysis of variance. When a
significant F ratio was obtained, further comparisons were deter-
mined by the Bonferroni post hoc test.
The Journal of ThoraciResults
Cell Preparations
Immediately before transplantation, the SMC cultures were
stained for -smooth muscle actin, and the percentage of
positive cells was 90% 3% (n 6). The efficacy of BrdU
labeling was 49%  7% (n  6). The cells that were
subjected to lethal injury (80°C for 5 minutes) were exam-
ined by light microscopy after culturing for 24 hours after
injury, and no cells survived the insult. The cells were
spherical and intact but could not attach on the culture dish
or proliferate.
Standard Curves for Real-Time PCR
Figure 2 shows the reproducibility of the Y-chromosome
quantification by this technique (n  4). The correlation
between the number of copies of male cell DNA and the
number of cycles detected by fluorescence exceeding the
threshold was excellent (r2  0.994).
Accuracy of Real-Time PCR
The correlation (r2  0.996; n  5) between the number of
male cells calculated from the standard curve and the num-
ber of male cells added to the female cells was excellent
(Figure 3, A). The accuracy of the PCR assay in measuring
the number of male cells added into female myocardial
tissue was satisfactory. The correlation between the number
of male cells calculated from the standard curve and the
number of male cells injected into the female myocardium
Figure 2. The reproducibility of the standard curve obtained by
real-time PCR is illustrated. A serial 10-fold dilution of the DNA
from the smooth muscle cells was tested 4 times in separate
experiments. Each circle corresponds to the result of 1 dilution in
1 assay. The solid line corresponds to the regression analysis (y
 41.44  3.93 log x; r2  0.994; P < .001).was 0.786 (n  5; Figure 3, B).
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Survival of Implanted Cells
Table 1 showed the number of dead cells measured at 1 hour
and 1 week after transplantation in normal and infarcted
myocardium. Approximately half of the injected cells were
detected at the implantation site in both normal and in-
farcted myocardium 1 hour after transplantation. At 1 week
after transplantation, no cells were detected in the trans-
planted area in either the normal or infarcted region.
Table 2 showed the number of male live cells trans-
planted into female normal myocardium. Similar to the
results obtained with the dead cells at 1 hour after trans-
plantation, only 50% of implanted cells were detected at the
Figure 3. A, In vitro assessment of the accuracy of male cell
quantification. Male smooth muscle cells (SMCs) were mixed
with female SMCs in a percentage varying from 0.1% to 100% in
a total of 105cells. Genomic DNA was extracted from the sample,
and the number of male cells was determined from the standard
curve (n  5). The solid line represents the linear regression
analysis (log y 0.99 log x 0.03; r2 0.996; P< .001). B, In vitro
evaluation of the accuracy of male cell determination. Male cells
(0.5, 1.0, 2.0, and 4.0  106) were injected into 300 mg of female
heart tissue (n  5 each). Genomic DNA was extracted, and the
number of male cells was determined from the standard curve.
The solid line represents the linear regression analysis (y 0.73x
 0.12; r2  0.786; P < .001).implanted area. At 1 or 4 weeks after transplantation, the
908 The Journal of Thoracic and Cardiovascular Surgery ● Aprinumber of cells transplanted into normal and infarcted myo-
cardium decreased (P .001) as compared with the number
at 1 hour after transplantation. Although the survival of
implanted cells tended to be higher when the cells were
transplanted into normal myocardium compared with the
numbers in the infarcted myocardium at 1 and 4 weeks after
transplantation, the difference was not statistically significant.
Measurement of Implanted Cells in the Lung, Brain,
and Kidney
At 1 hour after transplantation, the number of implanted
cells was 0.17 0.10 106 in the lungs, 0.03 0.03 106
in the kidneys, and none in the brain (n 5 per group). One
week after cell transplantation, no cells were found in the
lung, kidney, or brain (n  3 per group).
Histology
Four weeks after cell transplantation, the cells were identi-
fied in the implanted area of both normal and infarcted
myocardium in the live cell transplantation group by stain-
ing for BrdU (Figure 4). Mononuclear cell infiltration was
present at the transplanted area, indicating a mild immu-
norejection. In control animals and animals implanted with
dead cells, no BrdU staining was detected, and no cell
engraftment was found.
Discussion
Cell transplantation has been demonstrated to prevent car-
diac dilation and functional deterioration after myocardial
infarction in animals9-11 and in humans.2-4 The transplanted
cells engrafted, induced angiogenesis, and stimulated matrix
remodeling. The improvement in regional ventricular func-
tion was shown to be proportional to the number of muscle
cells injected.5 Because few studies have reported the sur-
TABLE 1. The number of lethally injured male cells trans-
planted into the heart with time
Recipient female myocardium
Time after transplantation
1 h 1 wk
Normal
No. rats 4 5
No. male cells (106) 0.92 0.18* 0  0*
No. male cells/2  106 cells (%) 46 0
Infarcted
No. rats 5 6
No. male cells (106) 0.82 0.22* 0  0*
No. male cells/2  106 cells (%) 41 0
A total of 2  106 male smooth muscle cells were lethally injured by
exposing them to 80°C for 5 minutes before transplantation into normal or
injured left ventricular free wall. The implanted cell number decreased ( *P
 .01 compared with implanted cell number) by 1 hour and was undetect-
able at 1 week.vival of injected cells, an accurate technique to quantify
l 2005
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could make a significant contribution to the science of cell
transplantation because increasing cell survival might en-
hance the number of cells engrafting in the infarcted myo-
cardium and might increase the functional recovery after
cell transplantation.
Real-time PCR is a promising technique to quantify the
TABLE 2. The number of live male cells after transplantat
Recipient female myocardium 1 h
Normal
No. rats 5
No. male cells (106) 0.97 0.2
No. male cells/2  106 cells (%) 49
Infarcted
No. rats 5
No. male cells (106) 1.05 0.2
No. male cells/2  106 cells (%) 53
A total of 2  106 male smooth muscle cells were transplanted into fem
decreased ( *P  .01 for all groups compared with implanted cell numbe
†P  .01 for all groups as compared with 1 hour after transplantation.
Figure 4. Histologic photomicrographs of the infarcted
smooth muscle cell transplantation. Hematoxylin-eosin
showed the implanted cells. The transplanted cells sta
adjacent to the H&E sections. Some mononuclear cel
muscle cells.number of surviving cells. The technique of quantitative
The Journal of Thoracianalysis of the Y chromosome in the female host was
applied by Lee and colleagues15,18 to evaluate donor male
leukocyte survival in female recipients. We used the same
primer pairs to target the Sry3 gene sequence in the rat Y
chromosome. We evaluated the method’s accuracy, sensi-
tivity, and reproducibility to quantify male muscle cells in
female myocardium. As shown in Figure 3, the standard
nto the heart with time
Time after transplantation
1 wk 4 wk
5 8
0.48 0.06*† 0.27 0.07*†
24 14
6 10
0.29 0.08*† 0.18 0.05*†
15 9
ormal or infarcted left ventricular free wall. The implanted cell numbers
1 hr, 1 wk, and 4 wks.
d B) and normal (C and D) myocardium at 4 weeks after
E) staining (A and C) of the transplanted myocardium
positively for BrdU (arrows in B and D) in the sections
g arrows) were present around the engrafted smoothion i
3*
7*
ale n
r) by(A an
(H&
ined
ls (bicurve was reproducible. The technique was also reliable and
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either female cells or female heart tissue. The number of
cardiomyocytes in the rat ventricle is approximately 120
million.8 We used half of the left ventricle for DNA extrac-
tion and were able to detect 60,000 cells (3% of the cells
initially injected). Theoretically, the minimum number of
male cells that could be measured was 10,000 cells, or 0.5%
of the cells initially injected. As many as 100 million cells
should be detectable on the basis of the dynamic range of
the method. The sensitivity of the technique was more than
adequate to quantify the number of cells surviving trans-
plantation.
The real-time PCR technique enabled us to measure the
number of male cells in female tissue. We found that
approximately half of the live or dead cells disappeared
within an hour after cell transplantation. Although we at-
tempted to avoid leakage of the cells through the epicardial
needle insertion site or into the ventricular cavity, the leak-
age might have occurred at the injection site, through the
needle tracts, as well as into the myocardial venous and
lymphatic systems. Because more cells were found in the
lungs than in the kidney or in the brain, the cells might have
escaped into the cardiac veins and lymphatics rather than
into the ventricular cavity. Although the SMCs used in this
study did not form tissue in nonmyocardial sites, leakage of
cells, such as embryonic or adult stem cells, could result in
a viable engraftment.19 Cell numbers in other organs, such
as liver, will need to be examined in future studies.
To accurately evaluate the survival of implanted viable
cells, we first investigate the time for the myocardium to
eliminate implanted dead cells. Most of the dead cell DNA
was removed within the first day after transplantation, and
all of the lethally injured cells were completely cleared by 1
week. Therefore, the number of cells surviving 1 and 4
weeks after cell transplantation represented viable engrafted
cells rather than the persistence of the DNA of irreversibly
injured cells. Our data were in agreement with those re-
ported by Müller-Ehmsen and colleagues,8 who injected
frozen cells into the hearts.
A substantial number of cells were lost between 1 hour
and 1 week after cell transplantation. The loss might be
explained by damage to the cell membranes when the cells
were injected through the fine needle, by ischemic injury
(especially in scar tissue), and by activation of apoptotic
pathways.20 If these injuries were an important cause of
early cell loss, strategies to prevent cell damage would be
expected to improve donor cell survival. The implantation
of cells into the middle of an infarct region might also
induce early cell attrition because of ischemic or traumatic
injury. Previous studies have suggested that cell engraft-
ment was better in the periphery than in the center of an
infarct region.21 However, muscle cell transplantation has
been shown to induce angiogenesis,22,23 and this could
910 The Journal of Thoracic and Cardiovascular Surgery ● Aprifacilitate long-term transplanted cell survival. Transfection
of donor cells with vascular endothelial grown factor or
pretreatment of the ischemic region with fibroblast growth
factor before cell transplantation might also enhance trans-
planted cell viability and functional improvement.17,24
The decrease in transplanted SMC number in both the
normal and infarcted myocardium might also be explained
by mild immunorejection, because a mild mononuclear in-
filtration was visible around the engrafted SMCs. Although
the Lewis rats were inbred, mild histocompatibility antigen
differences exist between male and female individuals.25
The male antigen H-Y may be important in graft rejection or
graft-versus-host disease when male cells are transplanted
into female organs, which could explain the presence of the
mononuclear infiltrate in our study. Future studies are re-
quired to determine whether antirejection therapy such as
cyclosporine (INN: ciclosporin) would increase cell sur-
vival when male cells are transplanted into the female heart.
Our results were similar to those reported by researchers
who have estimated cell survival after transplantation.
Müller-Ehmsen and associates8 found that 23% of neonatal
cardiomyocytes survived in the healthy rat myocardium 4
weeks after transplantation. The differences between their
results and ours could reflect a variety of factors that influ-
ence cell survival, engraftment, and improvement in ven-
tricular function. Neonatal cardiomyocytes could be more
resistant to cell injury during implantation and more prolif-
erative than adult SMCs after implantation. The number of
cells injected might correlate with the mechanical injury
suffered by the cells because of increased pressure in the
syringe during injection.
In summary, quantitative analysis of male donor cells
with real-time PCR targeting the Y chromosome was a
reliable method of evaluating donor cell survival. Signifi-
cant leakage of the implanted cells occurred and resulted in
the cells being trapped in nonmyocardial organs. Large-
animal studies using this PCR technique should help to
define the optimal conditions for cell transplantation to
fulfill the promise of cardiac regeneration.
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